<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548137" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548137/" /><meta name="ncbi_pagename" content="Chlorzoxazone - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Chlorzoxazone - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Chlorzoxazone" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2017/01/30" /><meta name="citation_pmid" content="31643467" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548137/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Chlorzoxazone" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2017/01/30" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548137/" /><meta name="description" content="Chlorzoxazone is a centrally acting muscle relaxant commonly used for low back pain. Chlorzoxazone has been linked to rare instances of acute liver injury, a few of which have been fatal." /><meta name="og:title" content="Chlorzoxazone" /><meta name="og:type" content="book" /><meta name="og:description" content="Chlorzoxazone is a centrally acting muscle relaxant commonly used for low back pain. Chlorzoxazone has been linked to rare instances of acute liver injury, a few of which have been fatal." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548137/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Chlorzoxazone/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548137/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A3D1C046554B10000000009220298.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK548137_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK548137_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Chlorpromazine/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Cholestyramine/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548137_"><span class="title" itemprop="name">Chlorzoxazone</span></h1><p class="small">Last Update: <span itemprop="dateModified">January 30, 2017</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Chlorzoxazone.OVERVIEW"><h2 id="_Chlorzoxazone_OVERVIEW_">OVERVIEW</h2><div id="Chlorzoxazone.Introduction"><h3>Introduction</h3><p>Chlorzoxazone is a centrally acting muscle relaxant commonly used for low back pain. Chlorzoxazone has been linked to rare instances of acute liver injury, a few of which have been fatal.</p></div><div id="Chlorzoxazone.Background"><h3>Background</h3><p>Chlorzoxazone (klor zox' a zone) acts centrally rather than directly on muscles to relieve muscle spasms, either through its sedative effects or other unknown mechanisms. Chlorzoxazone is indicated for therapy of low back pain and muscle spasms, although its overall efficacy is considered only fair. Chlorzoxazone was approved for use in the United States in 1958 and is still widely used. It is available in various generic forms as well as under the brand names of Parafon Forte and Remular in tablets of 250 or 500 mg. The usual recommended dose in adults is 250 to 750 mg orally three to four times daily, reducing the dose to lowest effective level once a response occurs. Chlorzoxazone is typically given for 1 to 4 weeks only. Common side effects of chlorzoxazone include dizziness, drowsiness, headache, fatigue and tremor.</p></div><div id="Chlorzoxazone.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>There have been no adequate prospective studies demonstrating the rates of <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> or <a class="def" href="/books/n/livertox/glossary/def-item/glossary.aspartate-aminotransferase-ast-/">AST</a> elevations on chlorzoxazone therapy. Rare instances of clinical apparent liver disease possibly attributable to chlorzoxazone have appeared, including fatal cases. Such cases must be very rare, as this agent is widely used. While case reports have been few, in many instances chlorzoxazone was clearly implicated; furthermore, a related muscle relaxant with similar structure (zoxazolamine) was withdrawn from use in 1961, largely because of hepatotoxicity. The usual latency period is 1 to 4 weeks and the pattern of disease typically hepatocellular with marked elevations in ALT levels and jaundice, with minimal increases in alkaline phosphatase. Cholestatic enzyme elevations after exposure to chlorzoxazone have also been described. Allergic manifestations (rash and fever) are common, particularly in cases with a short latency (Case 1); autoantibodies are rare. Recovery is rapid once chlorzoxazone is stopped, but fatal cases have been reported, with disease progression despite early discontinuation of the agent (Case 2). There is rapid recurrence of injury with reexposure, often accompanied by fever.</p><p>Likelihood score: B (Highly likely cause of clinically apparent liver injury).</p></div><div id="Chlorzoxazone.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The cause of acute hepatic injury from chlorzoxazone is unknown, but is clearly idiosyncratic and likely due to hypersensitivity.</p></div><div id="Chlorzoxazone.Outcome_and_Management"><h3>Outcome and Management</h3><p>The idiosyncratic liver injury due to chlorzoxazone ranges from mild, self-limited hepatitis to severe, protracted liver injury leading to death or need for liver transplantation. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.rechallenge/">Rechallenge</a> leads to rapid return of hepatic injury and should be avoided. No cross reactivity with other muscle relaxants has been identified.</p><p>Drug Class: <a href="/books/n/livertox/MuscleRelaxants/">Muscle Relaxants</a></p></div></div><div id="Chlorzoxazone.CASE_REPORTS"><h2 id="_Chlorzoxazone_CASE_REPORTS_">CASE REPORTS</h2><div id="Chlorzoxazone.Case_1._Skin_rash_and_chol"><h3>Case 1. Skin rash and cholestatic pattern of serum enzyme elevations from chlorzoxazone.</h3><p>[Modified from: Lindholm L. (Fever, skin and liver reactions in a patient treated with Paraflex comp.) Lakartidningen 1979; 76: 2795-6. <a href="https://www.ncbi.nlm.nih.gov/pubmed/160967" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 77 year old woman was treated with a combination of chlorzoxazone, dextropropoxyphene and aspirin ("Paraflex Compound") for acute neck pains and developed fever and rash four days later. The medications were continued and one week later she was still febrile and was found to have abnormal liver tests with marked elevations in alkaline phosphatase (6.5 fold elevated) and gamma glutamyl transpeptidase (8-fold increased), with minimal increases in <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> and <a class="def" href="/books/n/livertox/glossary/def-item/glossary.aspartate-aminotransferase-ast-/">AST</a> and normal bilirubin. Chlorzoxazone was stopped. The rash was considered to be erythema multiforme. She had a past medical history of osteoporosis and had received aspirin and nonsteroid antiinflammatory agents in the past. She tested negative for hepatitis markers and for autoantibodies. The fever and rash resolved within 1 to 2 weeks of stopping the medication. In follow up, all laboratory tests returned to normal. She later received aspirin without untoward reaction.</p><div id="Chlorzoxazone.Key_Points1"><h4>Key Points</h4><div id="Chlorzoxazone.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548137/table/Chlorzoxazone.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Chlorzoxazone.T1_lrgtbl__"><table><thead><tr><th id="hd_h_Chlorzoxazone.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Medication:</th><td rowspan="1" colspan="1" style="vertical-align:top;">Chlorzoxazone (in combination)</td></tr></thead><tbody><tr><th headers="hd_h_Chlorzoxazone.T1_1_1_1_1" id="hd_b_Chlorzoxazone.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</th><td headers="hd_b_Chlorzoxazone.T1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Cholestatic (R=0.3)</td></tr><tr><th headers="hd_h_Chlorzoxazone.T1_1_1_1_1" id="hd_b_Chlorzoxazone.T1_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">Severity:</th><td headers="hd_b_Chlorzoxazone.T1_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">1+ (enzyme elevations only)</td></tr><tr><th headers="hd_h_Chlorzoxazone.T1_1_1_1_1" id="hd_b_Chlorzoxazone.T1_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</th><td headers="hd_b_Chlorzoxazone.T1_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;">1 week</td></tr><tr><th headers="hd_h_Chlorzoxazone.T1_1_1_1_1" id="hd_b_Chlorzoxazone.T1_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</th><td headers="hd_b_Chlorzoxazone.T1_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Complete within several months</td></tr><tr><th headers="hd_h_Chlorzoxazone.T1_1_1_1_1" id="hd_b_Chlorzoxazone.T1_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</th><td headers="hd_b_Chlorzoxazone.T1_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Aspirin, dextropropoxyphene</td></tr></tbody></table></div></div></div><div id="Chlorzoxazone.Laboratory_Values1"><h4>Laboratory Values</h4><div id="Chlorzoxazone.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548137/table/Chlorzoxazone.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Chlorzoxazone.T2_lrgtbl__"><table><thead><tr><th id="hd_h_Chlorzoxazone.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Chlorzoxazone.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> (U/L)*</th><th id="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Alk P (U/L)*</th><th id="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)*</th><th id="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1 hd_h_Chlorzoxazone.T2_1_1_1_2 hd_h_Chlorzoxazone.T2_1_1_1_3 hd_h_Chlorzoxazone.T2_1_1_1_4 hd_h_Chlorzoxazone.T2_1_1_1_5 hd_h_Chlorzoxazone.T2_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">Fever and rash arising after 4 days</td></tr><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">11 days</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">84</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">750</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.6</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Rash and fever</td></tr><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">2 weeks</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3 days</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">60</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">600</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">3 weeks</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">8</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">24</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">500</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.5</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">11</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">12</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">350</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Asymptomatic</td></tr><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">5 weeks</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">4 weeks</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">12</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">167</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.5</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">8 weeks</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">7 weeks</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">18</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">142</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.4</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">10 weeks</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">9 weeks</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">12</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">122</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">0.6</td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Chlorzoxazone.T2_1_1_1_1 hd_h_Chlorzoxazone.T2_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;42</b></td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;115</b></td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Chlorzoxazone.T2_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div><p>* Converted from &#x003bc;kat/L (0.7=42) and &#x003bc;mol/L (17=1.0).</p></div><div id="Chlorzoxazone.Comment1"><h4>Comment</h4><p>This case was identified when the patient developed drug rash and fever. She was not jaundiced, but serum alkaline phosphatase levels were high typical of a cholestatic reaction (also confirmed by the elevations in <a class="def" href="/books/n/livertox/glossary/def-item/glossary.gamma-glutamyl-transpeptidase-ggt-/">GGT</a>). Once the medication was stopped, she became asymptomatic within a few weeks, but alkaline phosphatase levels took longer to return to normal. Because she also received dextropropoxyphene, one cannot consider the case definitely due to chlorzoxazone.</p></div></div><div id="Chlorzoxazone.Case_2._Acute_liver_failur"><h3>Case 2. Acute liver failure due to chlorzoxazole.</h3><p>[Modified from: Jackson J, Anania FA. Chlorzoxazone as a cause of acute liver failure requiring liver transplantation. Dig Dis Sci 2007; 52: 3389-91. <a href="https://www.ncbi.nlm.nih.gov/pubmed/17390222" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 38 year old woman developed nausea, vomiting and progressive jaundice 6 weeks after starting chlorzoxazone (500 mg twice daily) for low back pain. Her other medical conditions included hypertension, gastrointestinal reflux and atopic dermatitis. Her medications included hydrochlorothiazide, pantoprazole, iron sulfate and skin creams. She denied taking herbal remedies or other over-the-counter products. She had no history of liver disease, alcohol abuse, risk factors for viral hepatitis or drug allergies. When initially seen she was jaundiced and lethargic. Laboratory results showed total bilirubin of 19.9 mg/dL, <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> 1029 U/L, <a class="def" href="/books/n/livertox/glossary/def-item/glossary.aspartate-aminotransferase-ast-/">AST</a> 846 U/L and prothrombin time 32.6 seconds. Because of progressive symptoms and worsening, she was referred to a liver transplant center. On admission, she was deeply jaundiced and had mild axterixis. She had no fever or rash. Tests for hepatitis A, B and C were negative as were antinuclear and smooth muscle antibodies. A CT scan of the abdomen showed a mild amount of ascites and a nodular liver, but no evidence of biliary obstruction. Two weeks later and within 16 days of oneset she underwent emergency liver transplantation. The transplant was successful and she left the hospital in good condition.</p><div id="Chlorzoxazone.Key_Points2"><h4>Key Points</h4><div id="Chlorzoxazone.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548137/table/Chlorzoxazone.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Chlorzoxazone.T3_lrgtbl__"><table><thead><tr><th id="hd_h_Chlorzoxazone.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Medication:</th><td rowspan="1" colspan="1" style="vertical-align:top;">Chlorzoxazone (1000 mg daily)</td></tr></thead><tbody><tr><th headers="hd_h_Chlorzoxazone.T3_1_1_1_1" id="hd_b_Chlorzoxazone.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</th><td headers="hd_b_Chlorzoxazone.T3_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Hepatocellular</td></tr><tr><th headers="hd_h_Chlorzoxazone.T3_1_1_1_1" id="hd_b_Chlorzoxazone.T3_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">Severity:</th><td headers="hd_b_Chlorzoxazone.T3_1_1_2_1" rowspan="1" colspan="1" style="vertical-align:top;">5+ (liver transplantation)</td></tr><tr><th headers="hd_h_Chlorzoxazone.T3_1_1_1_1" id="hd_b_Chlorzoxazone.T3_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</th><td headers="hd_b_Chlorzoxazone.T3_1_1_3_1" rowspan="1" colspan="1" style="vertical-align:top;">6 weeks</td></tr><tr><th headers="hd_h_Chlorzoxazone.T3_1_1_1_1" id="hd_b_Chlorzoxazone.T3_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</th><td headers="hd_b_Chlorzoxazone.T3_1_1_4_1" rowspan="1" colspan="1" style="vertical-align:top;">Incomplete</td></tr><tr><th headers="hd_h_Chlorzoxazone.T3_1_1_1_1" id="hd_b_Chlorzoxazone.T3_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</th><td headers="hd_b_Chlorzoxazone.T3_1_1_5_1" rowspan="1" colspan="1" style="vertical-align:top;">HCTZ, iron, pantoprazole</td></tr></tbody></table></div></div></div><div id="Chlorzoxazone.Laboratory_Values2"><h4>Laboratory Values</h4><div id="Chlorzoxazone.T4" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548137/table/Chlorzoxazone.T4/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Chlorzoxazone.T4_lrgtbl__"><table><thead><tr><th id="hd_h_Chlorzoxazone.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Time After Starting</th><th id="hd_h_Chlorzoxazone.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Time After Stopping</th><th id="hd_h_Chlorzoxazone.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> (U/L)</th><th id="hd_h_Chlorzoxazone.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protime (sec)</th><th id="hd_h_Chlorzoxazone.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)</th><th id="hd_h_Chlorzoxazone.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Chlorzoxazone.T4_1_1_1_1 hd_h_Chlorzoxazone.T4_1_1_1_2 hd_h_Chlorzoxazone.T4_1_1_1_3 hd_h_Chlorzoxazone.T4_1_1_1_4 hd_h_Chlorzoxazone.T4_1_1_1_5 hd_h_Chlorzoxazone.T4_1_1_1_6" colspan="6" rowspan="1" style="vertical-align:top;">Nausea and vomiting starting 6 weeks after starting chlorzoxazone</td></tr><tr><td headers="hd_h_Chlorzoxazone.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">6 weeks</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">1029</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">32.6</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">19.9</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Admission</td></tr><tr><td headers="hd_h_Chlorzoxazone.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">4 days</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">1014</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">32.6</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">17.9</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">Transfer</td></tr><tr><td headers="hd_h_Chlorzoxazone.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">8 weeks</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">16 days</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">93</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">36.8</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">4.8</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Chlorzoxazone.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">9 weeks</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">19 days</td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_3 hd_h_Chlorzoxazone.T4_1_1_1_4 hd_h_Chlorzoxazone.T4_1_1_1_5 hd_h_Chlorzoxazone.T4_1_1_1_6" colspan="4" rowspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.liver-transplantation/">Liver transplantation</a></td></tr><tr><td headers="hd_h_Chlorzoxazone.T4_1_1_1_1 hd_h_Chlorzoxazone.T4_1_1_1_2" colspan="2" rowspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;42</b></td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;14</b></td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Chlorzoxazone.T4_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div></div><div id="Chlorzoxazone.Comment2"><h4>Comment</h4><p>A young woman developed acute liver failure with an abrupt onset and progressive course 6 weeks after starting chlorzoxazone. Medical evaluation showed no other cause for the acute liver failure. Despite prompt discontinuation of the muscle relaxant, she had a rapidly progressive course.</p></div></div></div><div id="Chlorzoxazone.PRODUCT_INFORMATION_Muscle"><h2 id="_Chlorzoxazone_PRODUCT_INFORMATION_Muscle_">PRODUCT INFORMATION</h2><div id="Chlorzoxazone.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Chlorzoxazone &#x02013; Generic, Parafon Forte&#x000ae;</p><p><b>DRUG CLASS</b></p><p>Autonomic Agents: Muscle Relaxants, Central</p><p><a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=chlorzoxazone" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"> COMPLETE LABELING</a></p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="Chlorzoxazone.CHEMICAL_FORMULA_AND_STRUC"><h2 id="_Chlorzoxazone_CHEMICAL_FORMULA_AND_STRUC_">CHEMICAL FORMULA AND STRUCTURE</h2><div id="Chlorzoxazone.T5" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548137/table/Chlorzoxazone.T5/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Chlorzoxazone.T5_lrgtbl__"><table><thead><tr><th id="hd_h_Chlorzoxazone.T5_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Chlorzoxazone.T5_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NO</th><th id="hd_h_Chlorzoxazone.T5_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Chlorzoxazone.T5_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Chlorzoxazone.T5_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Chlorzoxazone</td><td headers="hd_h_Chlorzoxazone.T5_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/134971727" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">95-25-0</a></td><td headers="hd_h_Chlorzoxazone.T5_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C7-H4-Cl-N-O2</td><td headers="hd_h_Chlorzoxazone.T5_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548137/bin/Chlorzoxazone_Structure.jpg" alt="Chlorzoxazone chemical structure" /></div></td></tr></tbody></table></div></div></div><div id="Chlorzoxazone.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Chlorzoxazone_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 30 January 2017</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Chlorzoxazone.R1">Zimmerman HJ. Muscle spasmolytics. In, Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. 2nd Ed. Philadelphia: Lippincott, 1999. p. 544-45.<div><i>(Expert review of hepatotoxicity published in 1999 mentions that chlorzoxazone was incriminated in at least 33 instances of liver injury which were usually hepatocellular).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R2">Hibbs RE, Zambon AC. Agents acting at the neuromuscular junction and autonomic ganglia. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman&#x02019;s The pharmacological basis of therapeutics, 12th ed. New York: McGraw-Hill, 2011. p. 255-76.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R3">Lindholm L. [Fever, skin and liver reactions in a patient treated with Paraflex comp.] Lakartidningen 1979; 76: 2795-6. Swedish.  [<a href="/pubmed/160967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 160967</span></a>]<div><i>(77 year old woman developed fever, rash after 4 days and cholestatic enzyme elevations after 11 days of a combination of chlorzoxazone, propoxyphene and aspirin without jaundice, resolving in 8 weeks: Case 1).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R4">[Effects on liver of analgesics containing dextropropoxyphene and/or chlorzoxazone.] Lakartidningen 1982; 79: 3823. Swedish.  [<a href="/pubmed/7154757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7154757</span></a>]<div><i>(Reports to Swedish Registry of 13 cases of hepatic injury due to Paraflex Comp that included aspirin and dextropropoxyphene in combination with chlorzoxazone).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R5">Powers BJ, Cattau EL Jr, Zimmerman HJ. Chlorzoxazone hepatotoxic reactions. An analysis of 21 identified or presumed cases. Arch Intern Med 1986; 146: 1183-6.  [<a href="/pubmed/3521519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3521519</span></a>]<div><i> (Case report and review of FDA reports; 55 year old woman developed jaundice 3-4 weeks after starting chlorzoxazone [peak bilirubin 9.0 mg/dL, ALT 720 U/L] and had a positive rechallenge with fever, nausea and jaundice within day of receiving one pill; review of 23 FDA cases, average age 45, latency either &#x0003c;1 month or variable hepatocellular enzyme pattern; 60% jaundiced, 22% fatal).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R6">Nightingale SL. Chlorzoxazone warning on hepatotoxicity is strengthened. JAMA 1995; 274: 1903.  [<a href="/pubmed/8568972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8568972</span></a>]<div><i>(FDA report that warning on hepatotoxicity has been added to labeling of chlorzoxazone; based largely on analysis of Powers [1986]).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R7">Chlorzoxazone hepatotoxicity. Med Lett Drugs Ther 1996; 38: 46.  [<a href="/pubmed/8628182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8628182</span></a>]<div><i>(Brief review of chlorzoxazone concludes that it is largely ineffective and can cause liver injury and therefore should be avoided).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R8">Pillans PI. Drug associated hepatic reactions in New Zealand: 21 years experience. N Z Med J 1996; 109: 315-9.  [<a href="/pubmed/8816722" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8816722</span></a>]<div><i>(In a large registry of cases of drug induced liver injury from New Zealand, chlorzoxazone is not listed among the 20 most common causes).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R9">Kronenberg A, Krohenbohl S, Zimmermann A, Streuli R. [Severe hepatocellular damage after administration of paracetamol and chlorzoxazone in therapeutic dosage.] Schweiz Rundsch Med Prax 1998; 87: 1356-60. German.  [<a href="/pubmed/9828666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9828666</span></a>]<div><i>(64 year old man developed jaundice 3-4 weeks after starting chlorzoxazone and acetaminophen combination tablets [bilirubin 35.5 mg/dL, ALT 2796 U/L, Alk P 180 U/L, INR 1.7], with centrozonal necrosis on liver biopsy and ultimate recovery).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R10">Bielecki JW, Schraner C, Briner V, Kuhn M. [Rhabdomyolysis and cholestatic hepatitis under treatment with simvastatin and chlorzoxazone.] Schweiz Med Wochenschr 1999; 129: 514-8. German.  [<a href="/pubmed/10322565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10322565</span></a>]<div><i>(73 year old woman developed myositis and liver injury 2 weeks after starting chlorzoxazone and 1 year after starting simvastatin [bilirubin 8.4 mg/dL, ALT 766 U/L, Alk P 160 U/L], with rapid resolution upon stopping both).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R11">Tanaka E, Terada M, Misawa S. Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther 2000; 25: 165-75.  [<a href="/pubmed/10886461" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10886461</span></a>]<div><i> (Chlorzoxazone is one of at least 70 substrates metabolized by CYP 2E1; its metabolism can be used as a test of liver function and to assess the activity of this enzyme that is induced by many toxins).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R12">Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004; 28: 140-75.  [<a href="/pubmed/15276195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15276195</span></a>]<div><i>(Systematic review of safety and efficacy of muscle relaxants, including chlorzoxazone for which there is limited or inconsistent data regarding its effectiveness).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R13">Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl 2004; 10: 1018-23.  [<a href="/pubmed/15390328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15390328</span></a>]<div><i>(Among ~50,000 liver transplants done in the US between 1990 and 2002, 270 [0.5%] were done for drug induced acute liver failure, but none were attributed to chlorzoxazone).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R14">Orellana M, Rodrigo R, Varela N, Araya J, Poniachi KJ, Csendes A, Smok G, et al. Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients. Hepatol Res 2006; 34: 57-63.  [<a href="/pubmed/16321567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16321567</span></a>]<div><i>(Chlorzoxazone is metabolized by CYP 2E1 activity and can be used to assess CYP 2E1 activity; among obese patients undergoing bariatic surgery, those with NASH had increased metabolism and increased CYP 2E1 activity).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R15">Jackson J, Anania FA. Chlorzoxazone as a cause of acute liver failure requiring liver transplantation. Dig Dis Sci 2007; 52: 3389-91.  [<a href="/pubmed/17390222" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17390222</span></a>]<div><i>(38 year old woman developed acute liver failure requiring transplantation 6 weeks after starting chlorzoxazone [bilirubin 17.9 mg/dL, ALT 1014 U/L, Alk P not given, INR 3.6]; first published report in ~10 years).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R16">Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52: 2065-76.  [<a href="/pmc/articles/PMC3992250/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3992250</span></a>] [<a href="/pubmed/20949552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20949552</span></a>]<div><i>(Among 1198 patients with acute liver failure enrolled in a US prospective study between 1998 and 2007, 133 were attributed to drug induced liver injury, but none were due to chlorzoxazone or other muscle relaxants).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R17">Bj&#x000f6;rnsson ES, Bergmann OM, Bj&#x000f6;rnsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013; 144: 1419-25.  [<a href="/pubmed/23419359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23419359</span></a>]<div><i>(In a population based study of drug induced liver injury from Iceland, 96 cases were identified over a 2 year period, but none were attributed to chlorzoxazone or other muscle relaxants).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R18">Hern&#x000e1;ndez N, Bessone F, S&#x000e1;nchez A, di Pace M, Brahm J, Zapata R, A Chirino R, et al. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. Ann Hepatol 2014; 13: 231-9.  [<a href="/pubmed/24552865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24552865</span></a>]<div><i> (Systematic review of literature of drug induced liver injury in Latin American countries published from 1996 to 2012 identified 176 cases, but none were attributed to chlrozoxazine or other muscle relaxants).</i></div></div></li><li><div class="bk_ref" id="Chlorzoxazone.R19">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al.; United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology 2015; 148: 1340-1352.e7.  [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div><i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, 5 [0.7%] were attributed to muscle relaxants, including one due to chlorzoxazone: a 46 year old man who developed jaundice 4 weeks after starting chlorzoxazone [bilirubin 3.0 rising to 10.2 mg/dL, ALT 4064 U/L, Alk P 123 U/L], with recovery after stopping).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548137</span><span class="label">PMID: <a href="/pubmed/31643467" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31643467</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Chlorpromazine/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/Cholestyramine/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK548137&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK548137/?report=reader">PubReader</a></li><li><a href="/books/NBK548137/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK548137" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK548137" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Chlorzoxazone. [Updated 2017 Jan 30].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK548137/pdf/Bookshelf_NBK548137.pdf">PDF version of this page</a> (117K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=Chlorzoxazone/AE+AND+Human%5BMH%5D+AND+(drug-induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI+OR+hepatitis,+toxic%5BMH%5D)+AND+(%222009/12/01/1%22%5BEDat%5D%3A%222999/12/31%22%5BEDat%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Chlorzoxazone: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=Chlorzoxazone" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Chlorzoxazone: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4863876" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pcsubstance&amp;IdsFromResult=4863876" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4863876" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12480161" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Stimulatory effects of chlorzoxazone, a centrally acting muscle relaxant, on large conductance calcium-activated potassium channels in pituitary GH3 cells.</a><span class="source">[Brain Res. 2003]</span><div class="brieflinkpop offscreen_noflow">Stimulatory effects of chlorzoxazone, a centrally acting muscle relaxant, on large conductance calcium-activated potassium channels in pituitary GH3 cells.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Liu YC, Lo YK, Wu SN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain Res. 2003 Jan 3; 959(1):86-97. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27306492" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The effect of chlorzoxazone on acute pain after spine surgery. A randomized, blinded trial.</a><span class="source">[Acta Anaesthesiol Scand. 2016]</span><div class="brieflinkpop offscreen_noflow">The effect of chlorzoxazone on acute pain after spine surgery. A randomized, blinded trial.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nielsen RV, Fomsgaard JS, Siegel H, Martusevicius R, Mathiesen O, Dahl JB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Acta Anaesthesiol Scand. 2016 Sep; 60(8):1152-60. Epub 2016 Jun 16.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/7791086" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off.</a><span class="source">[J Pharmacol Exp Ther. 1995]</span><div class="brieflinkpop offscreen_noflow">Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jayyosi Z, Knoble D, Muc M, Erick J, Thomas PE, Kelley M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pharmacol Exp Ther. 1995 Jun; 273(3):1156-61. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643411" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Baclofen</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Baclofen<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/3521519" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Chlorzoxazone hepatotoxic reactions. An analysis of 21 identified or presumed cases.</a><span class="source">[Arch Intern Med. 1986]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Chlorzoxazone hepatotoxic reactions. An analysis of 21 identified or presumed cases.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Powers BJ, Cattau EL Jr, Zimmerman HJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Arch Intern Med. 1986 Jun; 146(6):1183-6. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31643467" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31643467" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="&#10;                        HTOn&#10;                    "><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T14:34:41-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal103&amp;ncbi_phid=CE8A3D1C046554B10000000009220298&amp;ncbi_session=CE8A3D1C0467C501_2338SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK548137%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548137&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548137/&amp;ncbi_pagename=Chlorzoxazone - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A3D1C0467C501_2338SID /projects/books/PBooks@9.2 portal103 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>